Gries Financial’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Gries Financial's BMY Position: Q3 2025 in Review
Gries Financial increased its Bristol-Myers Squibb (BMY) stake by 1.5% in Q3 2025, buying an estimated $33.7K and bringing the position to 50,378 shares worth $2.27M. The position accounts for 0.36% of the portfolio, ranked #56.
Gries Financial first reported a position in BMY in Q1 2021 and has held it in 19 quarters since. The position peaked at $3.69M in Q1 2024. 2,274 funds tracked by Wall St. Rank hold BMY as of Q3 2025.
- Gries Financial held 50,378 shares of Bristol-Myers Squibb worth $2.27M as of Q3 2025.
- Gries Financial bought 722 Bristol-Myers Squibb shares in Q3 2025, an estimated $33.7K.
- Bristol-Myers Squibb made up 0.36% of Gries Financial's portfolio in Q3 2025, its #56 holding.
- Gries Financial first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 19 quarters since.
- Gries Financial's Bristol-Myers Squibb position peaked at $3.69M in Q1 2024.
- 2,274 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.
Based on Gries Financial's 13F filing for Q3 2025, filed 22 Oct 2025.